NVNO Insider Trading Activity and SEC Form 4 Filings
NVNO insider trading summary
Over the past 12 months, insiders at enVVeno Medical Corp (NVNO) reported 3 sales worth $3K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $3K.
Latest NVNO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Francis Duhay | Director | Sell | $123 (11 @ $11.21) |
| Jun 11, 2026 | Francis Duhay | Director | Sell | $1K (140 @ $10.30) |
| Dec 11, 2025 | Francis Duhay | Director | Sell | $2K (4,900 @ $0.36) |
| Sep 15, 2025 | Francis Duhay | Director | Sell | $4K (4,900 @ $0.83) |
| Dec 31, 2024 | Robert Gray | Director | Buy | $10K (3,500 @ $2.94) |
| Dec 31, 2024 | Francis Duhay | Director | Buy | $250K (81,433 @ $3.07) |
| Dec 24, 2024 | Sanjay Shrivastava | Director | Buy | $16K (5,400 @ $2.90) |
| Dec 19, 2024 | Robert Andrew Berman | Chief Executive Officer | Buy | $31K (12,000 @ $2.55) |
| Dec 19, 2024 | Matthew Jenusaitis | Director | Buy | $24K (9,620 @ $2.53) |
| Mar 13, 2024 | Hamed Alavi | Chief Technology Officer | Sell | $52K (8,334 @ $6.22) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.